Literature DB >> 19057021

Nox4 acts as a switch between differentiation and proliferation in preadipocytes.

Katrin Schröder1, Katalin Wandzioch, Ina Helmcke, Ralf P Brandes.   

Abstract

OBJECTIVE: Insulin promotes differentiation of preadipocytes into adipocytes. Insulin also stimulates reactive oxygen species (ROS) production, and the NADPH oxidases Nox1 and Nox4 are important sources of ROS. We determined in human and mouse preadipocytes whether Nox proteins contribute to ROS formation and differentiation in response to insulin. METHODS AND
RESULTS: The expression of Nox1 and Nox4 was increased during insulin-induced differentiation, and insulin increased ROS production. SiRNA against Nox4 but not Nox1 inhibited insulin-induced differentiation and ROS production but promoted proliferation. Nox4 overexpression yielded the opposite effect. As observed by siRNA and overexpression, Nox4 controlled the expression of MAP kinase phosphatase-1 (MKP-1), which reduces insulin-induced ERK1/2 activation. Consequently, downregulation of Nox4 promoted ERK1/2 signaling: Proliferation was increased and through phosphorylation of the inhibitory site serine612, ERK1/2 inhibited the activation of the insulin-receptor substrate-1 (IRS-1) and thereby prevented differentiation in response to insulin. Inhibition of ERK1/2 or overexpression of MPK-1 promoted insulin-induced differentiation. Accordingly, insulin-induced proliferation was enhanced by siRNA against MKP-1, whereas inhibition of ERK1/2 or overexpression of MKP-1 attenuated proliferation.
CONCLUSIONS: Nox4 acts as a switch from insulin-induced proliferation to differentiation by controlling MKP-1 expression, which limits ERK1/2 signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057021     DOI: 10.1161/ATVBAHA.108.174219

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  100 in total

1.  Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats.

Authors:  Jin-Ran Chen; Oxana P Lazarenko; Kartik Shankar; Michael L Blackburn; Charles K Lumpkin; Thomas M Badger; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2010-11-22       Impact factor: 4.030

2.  NADPH oxidases and atherosclerosis: unraveling the details.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

3.  NADPH oxidase 4 represents a potential target for the treatment of osteoporosis.

Authors:  Paula Hoff; Frank Buttgereit
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

4.  NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle.

Authors:  Roman Ginnan; Frances L Jourd'heuil; Benjamin Guikema; Malorie Simons; Harold A Singer; David Jourd'heuil
Journal:  Free Radic Biol Med       Date:  2012-09-26       Impact factor: 7.376

Review 5.  NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Authors:  Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 6.  ROS signaling and ER stress in cardiovascular disease.

Authors:  Cristhiaan D Ochoa; Ru Feng Wu; Lance S Terada
Journal:  Mol Aspects Med       Date:  2018-03-22

7.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.

Authors:  Elyse Di Marco; Stephen P Gray; Kit Kennedy; Cedric Szyndralewiez; Alicia N Lyle; Bernard Lassègue; Kathy K Griendling; Mark E Cooper; Harald H H W Schmidt; Karin A M Jandeleit-Dahm
Journal:  Free Radic Biol Med       Date:  2016-07-19       Impact factor: 7.376

Review 9.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

Review 10.  Emerging role of Nrf2 in adipocytes and adipose biology.

Authors:  Kevin S Schneider; Jefferson Y Chan
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.